Acute effects of exposure to vapours of dioxane in humans

Human and Experimental Toxicology

Volumn 25, Issue 12, 2006, Pages 723-729

  Ernstgård, Lena ^a   Iregren, A ^b   Sjogren B ^a   Johanson, G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

Author keywords

Acute effects; Dioxane; Human; Irritation

Indexed keywords

C REACTIVE PROTEIN; DIOXANE; INTERLEUKIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EYELID REFLEX; FEMALE; HUMAN; LUNG FUNCTION; MALE; NOSE CAVITY; PRIORITY JOURNAL; SYMPTOMATOLOGY; VAPOR; VISUAL ANALOG SCALE;

ADULT; AIR POLLUTANTS; BLINKING; C-REACTIVE PROTEIN; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INHALATION EXPOSURE; INTERLEUKIN-6; IRRITANTS; MALE; MIDDLE AGED; NASAL CAVITY; NO-OBSERVED-ADVERSE-EFFECT LEVEL; REFERENCE VALUES; RESPIRATION; SPIROMETRY; TIME FACTORS; VOLATILIZATION;

EID: 33846202509     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327106073805     Document Type: Article

References (18)

1. DeRosa CT, Wilbur S, Holler J, Richter P, Stevens YW. Health evaluation of 1,4-dioxane. Toxicol Ind Health 1996; 12: 1-43.
2. SCOEL. Occupational exposure limits for 1,4-dioxane. Recommendations of the Scientific Committee for Occupational Exposure Limits to chemical agents. Office for Official Publications of the European Communities, 2005.
3. Young JD, Braun WH, Rampy LW, Chenoweth MB, Blau GE. Pharmacokinetics of 1,4-dioxane in humans. J Toxicol Environ Health 1977; 3: 507-20.
4. ACGIH. 1,4-Dioxane. Documentation of the threshold limit values and biological exposure indices, seventh edition. American Conference of Governmental Industrial Hygienists, 2001.
5. IARC. Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. IARC Monogr Eval Carcinog Risks Hum 1999; 71: 589-602.
6. Thiess A, Tress E, Fleig I. Arbeitsmedizinische Untersuchungsergebnisse von Dioxan-exponierten Mitarbeitern. Präventivmedicine 1976; 11: 36-46.
7. Buffler PA, Wood SM, Suarez L, Kilian DJ. Mortality follow-up of workers exposed to 1,4-dioxane. J Occup Med 1978; 20: 255-59.
8. Falk A, Löf A, Hagberg M, Wigeaus Hjelm EW, Wang Z. Human exposure to 3-carene by inhalation: toxicokinetics, effects on pulmonary function and occurrence of irritative and CNS symptoms. Toxicol Appl Pharmacol 1991; 110: 198-205.
9. Iregren A, Tesarz M, Wigaeus-Hjelm E. Human experimental MIBK exposure: effects on heart rate, performance, and symptoms. Environ Res 1993; 63: 101-108.
10. Järnberg J, Johanson G, Löf A. Toxicokinetics of inhaled trimethylbenzenes in man. Toxicol Appl Pharmacol 1996; 140: 281-88.
11. Ernstgård L, Gullstrand E, Löf A, Johanson G. Are women more sensitive than men to 2-propanol and m-xylene vapours? Occup Environ Med 2002; 59: 759-67.
12. Taylor G, Macneil AR, Freed DL. Assessing degree of nasal patency by measuring peak expiratory flow rate through the nose. J Allergy Clin Immunol 1973; 52: 193-98.
13. Nihlén A, Wålinder R, Löf A, Johansson G. Experimental exposure to methyl tertiary-butyl ether II. Acute effects in humans. Toxicol Appl Pharmacol 1998; 148: 281-87.
14. Ernstgård L, Sjögren B, Iregren A, Johanson G. Acute effects of exposure to vapours of acetic acid in humans. Toxicol Lett 2005; 165: 22-30.
15. Ernstgård L, et al. Acute effects of exposure to vapours of hexanal in humans. J Occup Environ Med 2005; 48: 573-80.
16. Hellman TM, Small FH. Characterization of the odor properties of 101 petrochemicals using sensory methods. J Air Pollut Control Assoc 1974; 24: 979-82.
17. Bentivoglio AR, et al. Analysis of blink rate patterns in normal subjects. Move Disord 1997; 12: 1028-34.
18. Vgontzas AN, et al. IL-6 and its circadian secretion in humans. Neuroimmunomodulation 2005; 12: 131-40.